CVE-2026-15415

5.5 MEDIUM
Published: July 17, 2026 Modified: July 17, 2026
View on NVD

Description

AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.

AI Explanation

Get an AI-powered plain-language explanation of this vulnerability and remediation steps.

Login to generate AI explanation

CVSS v3.x Details

0.0 Low Medium High Critical 10.0
Vector String
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N

References to Advisories, Solutions, and Tools

Patch Vendor Advisory Exploit Third Party Advisory

3 reference(s) from NVD

Quick Stats

CVSS v3 Score
5.5 / 10.0
Exploitation Status
Not in CISA KEV

Weaknesses (CWE)